Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.65 - $7.86 $25,735 - $35,802
4,555 Added 1.22%
378,450 $2.22 Million
Q3 2022

Nov 14, 2022

SELL
$4.63 - $8.0 $350,796 - $606,128
-75,766 Reduced 16.85%
373,895 $2.53 Million
Q2 2022

Aug 15, 2022

BUY
$2.84 - $5.0 $359,524 - $632,965
126,593 Added 39.18%
449,661 $2.08 Million
Q1 2022

May 16, 2022

BUY
$3.74 - $6.63 $353,721 - $627,052
94,578 Added 41.39%
323,068 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$5.48 - $9.86 $1.25 Million - $2.25 Million
228,490 New
228,490 $1.42 Million

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $59.3M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.